Edition:
United States

Catabasis Pharmaceuticals Inc (CATB.OQ)

CATB.OQ on NASDAQ Stock Exchange Global Market

1.74USD
10:59am EST
Change (% chg)

$-0.05 (-2.79%)
Prev Close
$1.79
Open
$1.78
Day's High
$1.78
Day's Low
$1.73
Volume
5,828
Avg. Vol
146,926
52-wk High
$5.50
52-wk Low
$1.08

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.25 -0.311
Jun '17 0.00 -0.320
Mar '17 0.00 -0.412
FY 2016 Dec '16 0.00 -0.469
Sep '16 0.00 -0.543
Jun '16 0.00 -0.614
Mar '16 0.00 -0.614
FY 2015 Dec '15 0.00 -0.626
Sep '15 0.00 -0.555
Jun '15 0.00 -0.525
Mar '15 0.00 -0.469
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 1 0.25 0.25 0.25 0.00
Year Ending Dec-17 1 0.50 0.50 0.50 1.67
Year Ending Dec-18 1 0.25 0.25 0.25 25.00
Earnings (per share)
Quarter Ending Dec-17 2 -0.33 -0.31 -0.35 -0.54
Quarter Ending Mar-18 1 -0.20 -0.20 -0.20 --
Year Ending Dec-17 2 -1.41 -1.35 -1.47 -2.15
Year Ending Dec-18 2 -1.09 -1.00 -1.17 -1.80
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 186.11 35.51
P/E High - Last 5 Yrs. -- 274.30 45.27
P/E Low - Last 5 Yrs. -- 92.17 24.24
Beta -- 0.83 0.91
Price to Sales (TTM) 165.28 113.99 5.83
Price to Book (MRQ) 2.62 21.50 5.68
Price to Tangible Book (MRQ) 2.64 25.23 7.26
Price to Cash Flow (TTM) -- 101.64 24.44
% Owned Institutions 37.24 5.68 1.39

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.96 5.23
Payout Ratio(TTM) -- 95.86 45.95

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -2.88 6.82
Sales (TTM) vs TTM 1 Yr. Ago -- 30.21 5.65
Sales - 5 Yr. Growth Rate -- 33.15 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 42.70 -147.47 7.23
EPS (TTM) vs TTM 1 Yr. Ago 36.90 -- --
EPS - 5 Yr. Growth Rate -- 43.45 10.90
Capital Spending - 5 Yr. Growth Rate -- 40.96 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.54
Current Ratio (MRQ) 3.02 5.75 3.56
LT Debt to Equity (MRQ) 0.00 14.45 13.23
Total Debt to Equity (MRQ) 21.05 16.90 19.24
Interest Coverage (TTM) -48.42 -147.16 44.55

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.05 54.80
Gross Margin - 5 Yr. Avg. -- 55.37 52.40
EBITD Margin (TTM) -11,976.00 -- --
EBITD - 5 Yr. Avg -- -219.17 15.52
Operating Margin (TTM) -12,122.00 -631.99 6.76
Operating Margin - 5 Yr. Avg. -- -236.03 11.03
Pre-Tax Margin (TTM) -12,258.00 -602.68 7.58
Pre-Tax Margin - 5 Yr. Avg. -- -236.35 11.44
Net Profit Margin (TTM) -12,258.00 -600.25 3.81
Net Profit Margin - 5 Yr. Avg. -- -239.62 7.73
Effective Tax Rate (TTM) -- 15.32 24.25
Effective Tax Rate - 5 Yr. Avg. -- 18.76 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 6,579 21,633,432 858,823,705
Net Income/Employee (TTM) -806,447 -1,703,997 100,224,560
Receivable Turnover (TTM) -- 25.40 6.12
Inventory Turnover (TTM) -- 2.62 3.55
Asset Turnover (TTM) 0.01 0.42 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -84.83 -9.13 11.35
Return on Assets - 5 Yr. Avg. -- 0.30 12.32
Return on Investment (TTM) -109.15 -11.32 14.47
Return on Investment - 5 Yr. Avg. -- 3.50 16.13
Return on Equity (TTM) -116.70 -35.69 16.06
Return on Equity - 5 Yr. Avg. -- 5.92 17.32
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -4.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Catabasis Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 37.24%
# of Holders: 31
Total Shares Held: 8,596,611
3 Mo. Net Change: 61,086
# New Positions: 6
# Closed Positions: 4
# Increased Positions: 14
# Reduced Positions: 9
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.